HIGH RISK PROSTATE CARCINOMA
Clinical trials for HIGH RISK PROSTATE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HIGH RISK PROSTATE CARCINOMA trials appear
Sign up with your email to follow new studies for HIGH RISK PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a drug plus precision radiation stop prostate cancer from spreading?
Disease control Recruiting nowThis phase III trial is testing whether adding the drug darolutamide and a precise, high-dose radiation technique (SBRT) to standard hormone therapy and radiation can help men with high-risk localized prostate cancer live longer without the cancer spreading. About 700 men will be…
Matched conditions: HIGH RISK PROSTATE CARCINOMA
Phase: PHASE3 • Sponsor: UNICANCER • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New MRI could reveal prostate cancer treatment success in weeks
Knowledge-focused Recruiting nowThis study is testing whether a special type of MRI scan can show early signs that high-risk prostate cancer is responding to treatment. About 32 men will get the scan before and during therapy, and results will be compared to standard tissue exams after surgery. The goal is to f…
Matched conditions: HIGH RISK PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: Ivan de Kouchkovsky, MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC